El lado oscuro de la DES Dr. Alexandre Abizaid y Dr. Jean Fajadet

More articles by this author

Perspectivas sobre el stent intravascular al final del camino Dr. Julio Palmaz

Perspectivas sobre el stent intravascular al final del camino Dr. Julio Palmaz

¿Qué DES actual no debe faltar en mi lista? Dr. Eduardo Sousa

¿Qué DES actual no debe faltar en mi lista? Dr. Eduardo Sousa

PFO Closure: Indications, Tecniques & Outcome Ziyad M. Hijazi

PFO Closure: Indications, Tecniques & Outcome Ziyad M. Hijazi

Manejo de la enfermedad de tronco coronario izquierdo y múltiples vasos: No debemos ignorar el contexto histórico Dr. Valentín Fuster

Manejo de la enfermedad de tronco coronario izquierdo y múltiples vasos: No debemos ignorar el contexto histórico Dr. Valentín Fuster

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....